Ping Wang

USPTO Granted Patents = 34 (Patent Applications = 7)

CIPO Patents = 10 (Patent Applications = 6)

EPO Patents = 12 (Patent Applications = 8)

Average Co-Inventor Count = 1.6

ph-index = 11

Forward Citations = 336(Granted Patents)

Location History:

Benicia, CA (US) (1998 - 1999)
Hicksville, NY (US) (2013)
Rosyln, NY (US) (2014)
Irvine, CA (US) (2007 - 2017)
Newport Coast, CA (US) (2018)
Roslyn, NY (US) (2005 - 2022)
Nutley, NJ (US) (2001 - 2023)

Company Filing History:

11 out of 89

The Feinstein Institute for Medical Research

patents

6 out of 4,942

Hoffmann-la Roche Inc.

Madrigal Pharmaceuticals, Inc.

patents

5. 3 out of 61

The Feinstein Institutes for Medical Research

patents

6. 2 out of 15,458

University of California

patents

7. 1 out of 2

Testrite Baparoma International, LLC

10. 5 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2023

Loading Chart...

34 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11564926 - Methods of synthesizing thyroid hormone analogs and polymorphs thereof (2023-01-31),

2. 11266716 - Use of dermcidin in sterile inflammatory conditions (2022-03-08),

3. 11083777 - Hemichannel extracellular-domain specific agents for treating ischemia-reperfusion injury (2021-08-10),

4. 10894050 - Methods of synthesizing thyroid hormone analogs and polymorphs thereof (2021-01-19),

5. 10548949 - Hemichannel extracellular-domain specific agents for treating sepsis (2020-02-04),

6. 10376517 - Methods of synthesizing thyroid hormone analogs and polymorphs thereof (2019-08-13),

7. 10265383 - Treatment of radiation injury using ghrelin (2019-04-23),

8. 9957295 - Peptides inhibiting cold-inducible RNA binding protein activity (2018-05-01),

9. 9878006 - Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels (2018-01-30),

10. 9669070 - Treatment and prevention of radiation injury using MFG-E8 (2017-06-06),

11. 9662059 - Imaging agents for monitoring changes of dopamine receptors and methods of using thereof (2017-05-30),

12. 9321822 - Milk fat globule epidermal growth factor—factor VIII and sepsis (2016-04-26),

13. 9266861 - Method of synthesizing thyroid hormone analogs and polymorphs thereof (2016-02-23),

14. 9109023 - Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP) (2015-08-18),

15. 9107917 - [object Object] (2015-08-18),

Title: Innovations of Ping Wang: A Leader in Medical Research Patents

Introduction

Ping Wang, located in Roslyn, NY, is a prominent inventor with a remarkable portfolio of 20 patents. His contributions to the field of medical research have significantly advanced the understanding and treatment of various conditions, particularly in inflammation and ischemia-reperfusion injuries.

Latest Patents

Among his latest patents, one notable innovation is the use of dermcidin in sterile inflammatory conditions. This patent outlines a method for treating sterile inflammatory conditions by utilizing an isolated dermcidin peptide or its active fragments or analogs. Additionally, it provides a method for inhibiting organ transplantation-associated ischemia/reperfusion and inflammation.

Another significant patent focuses on hemichannel extracellular-domain specific agents for treating ischemia-reperfusion injury. This method involves administering an antagonist of Panx1 hemichannel protein or an antagonist of Cx43 hemichannel protein for the treatment of sepsis or endotoxemia.

Career Highlights

Ping Wang has made significant strides in his career, contributing to vital research while working at esteemed institutions, such as The Feinstein Institute for Medical Research. His dedication to advancing medical science has earned him recognition in the field, particularly for his innovative approaches to complex health issues.

Collaborations

Throughout his career, Ping Wang has collaborated with fellow researchers and experts, including esteemed coworkers such as Haichao Wang and Wei Li. These partnerships have played a vital role in fostering innovation and bringing valuable medical advancements to fruition.

Conclusion

In conclusion, Ping Wang's work and patents highlight his commitment to improving healthcare solutions. His research and innovative methodologies have not only deepened the scientific community’s understanding of sterile inflammatory conditions and ischemia-reperfusion injuries but also paved the way for new treatment avenues. With a prolific record of patents, Ping Wang remains a significant figure in the realm of medical research innovation.

This text is generated by artificial intelligence and may not be accurate.